Radiotherapy patterns of practice: T1N0 glottic cancer in Ontario, Canada

Clinical Oncology

Volumn 15, Issue 5, 2003, Pages 266-279

  Jackson, L D ^a   Groome, Patti A ^a   Schulze, K ^a   O'Sullivan, B ^b   Irish, J C ^b   Dixon, P F ^c   Eapen, L J ^d   Gulavita, S P ^e   Hammond, J A ^f   Hodson, D I ^g   Mackenzie, R G ^h   Bissett, R J ⁱ   Schneider, K M ^j   Warde, P R ^b   Mackillop, W J ^a  

^a Radiation Oncology Research Unit   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c Cancer Centre of South Eastern Ontario   (Canada)

^d OTTAWA REGIONAL CANCER CENTRE   (Canada)

^e Northwestern Ontario Regional Cancer Centre   (Canada)

^f LONDON REGIONAL CANCER PROGRAM   (Canada)

^g JURAVINSKI CANCER CENTRE   (Canada)

^h Northeastern Ontario Regional Cancer Centre   (Canada)

ⁱ Centre Regional De Cancerologie De Windsor   (Canada)

^j NONE

more..

Author keywords

Glottic cancer; Patterns of practice; Radiotherapy

Indexed keywords

COBALT 60;

ADULT; AGED; ARTICLE; CANADA; CANCER CENTER; CANCER RADIOTHERAPY; CHIN; CLINICAL PRACTICE; COBALT THERAPY; CONTROLLED STUDY; FEMALE; GLOTTIS; HEAD POSITION; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HUMAN; IMMOBILIZATION; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; MEGAVOLTAGE RADIOTHERAPY; NECK; PATIENT POSITIONING; POPULATION RESEARCH; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RADIATION BEAM; RADIATION DOSE FRACTIONATION; RADIATION ENERGY; RADIATION FIELD; RANDOMIZATION; SAMPLING; SUPINE POSITION;

EID: 0042628114     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0936-6555(03)00112-2     Document Type: Article

References (74)

1. Groome PA, O'Sullivan B, Irish JC, et al. Glottic cancer in Ontario, Canada and the SEER areas of the United States: do different management philosophies produce different outcome profiles? J Clin Epidemiol 2001;54:301-315.
2. Groome PA, Mackillop WJ, Rothwell D, et al. The management and outcome of glottic cancer: a population-based comparison between Ontario, Canada and the SEER areas of the United States. J Otolaryngol 2000;29:67-77.
3. Skladowski K, Tarnawski R, Maciejewski B, et al. Clinical radiobiology of Glottic T1 squamous cell carcinoma. Int J Radiat Oncol Biol Phys 1999;43:101-106.
4. Dinshaw KA, Sharma V, Agarwal JP, et al. Radiation therapy in T1-T2 glottic carcinoma: influence of various treatment parameters on local control/complications. Int J Radiat Oncol Biol Phys 2000; 48:723-735.
5. Head and neck carcinoma of the larynx. Vancouver, British Columbia Cancer Agency; 1-8-2003. Available online: http://www.bccancer.bc.ca.
6. National Comprehensive Cancer Network. Head and Neck Cancers-Glottic Larynx Practice Guidelines. Report No. v1.2001.
7. Agency for Healthcare Research, American Medical Association, and American Association of Health Plans. National Guideline Clearinghouse. National Guideline Clearinghouse; 1-2-2003. Available online: http://www.guidelines.gov/body_home.asp.
8. Vokes EE. Head and Neck Cancer. Best practice of medicine; 4-23-2002. Available online: http://merck.praxis.md/bpm/bpmviewall?page=CPM01ON233.
9. American Head and Neck Society. Practice Guidelines: Larynx, Glottic. 1-2-2003. Available online: http://www.headandneckcancer.org/doc/40.
10. Snyder MC. Glottic Cancer. FSU College of Medicine eMedicine: instant access to the minds of medicine. 5-9-2002. Available online: http.//www.emedicine.com/enttopic688.htm.
11. Hodson I, Archibald S, Browman GP, et al. Head and Neck Cancer Disease Site Group. Optimum radiation fractionation for T1 N0 Glottic (vocal cord) carcinoma. Curr Oncol 2000;7:91-97.
12. Teshima T, Chatani M, Inoue T. Radiation therapy for early glottic cancer (T1N0M0): II. prospective randomized study concerning radiation field. Int J Radiat Oncol Biol Phys 1990; 18:119-123.
13. O'Sullivan B, Mackillop W, Gilbert R, et al. Controversies in the management of laryngeal cancer: results of an international survey of patterns of care. Radiother Oncol 1994;31:23-32.
14. Goel V, Williams JI, Anderson GM, et al. Patterns of health care in Ontario. In: The ICES practice atlas. 2nd ed. Ottawa: Canadian Medical Association, 1996.
15. Task Force on Principles for Economic Analysis of Health Care Technology. Economic analysis of health care technology: a report on principles. Ann Intern Med 1995;122:61-70.
16. Vayda EA. Comparison of surgical rates in Canada and in England and Wales. N Engl J Med 1973;289:1224-1229.
17. Chassin MR, Brook RH, Park RE, et al. Variations in the use of medical and surgical services by the Medicare population. N Engl J Med 1986;314:285-290.
18. Lavis JN, Malter A, Anderson GM, et al. Trends in hospital use for mechanical neck and back problems in Ontario and the United States: discretionary care in different health care systems. Can Med Assoc J 1998;158:29-36.
19. McPherson K, Wennberg JE, Hovind OB, et al. Small-area variations in the use of common surgical procedures: an international comparison of New England, England, and Norway. N Engl J Med 1982;307:1310-1314.
20. Terhaard CH, Snippe K, Ravasz LA, et al. Radiotherapy in T1 laryngeal cancer: prognostic factors for locoregional control and survival, uni- and multivariate analysis. Int J Radiat Oncol Biol Phys 1991;21:1179-1186.
21. Lusinchi A, Dube P, Wibault P, et al. Radiation therapy in the treatment of early glottic carcinoma: The experience of Villejuif. Radiother Oncol 1989;15:313-319.
22. Akine Y, Tokita N, Ogino T, et al. Radiotherapy of T1 glottic cancer with 6 MeV X Rays. Int J Radiat Oncol Biol Phys 1991; 20:1215-1218.
23. Harwood AR, Hawkins NV, Rider WD. Radiotherapy of early glottic cancer-1. Int J Radiat Oncol Biol Phys 1979;5:473-476.
24. Cellai E, Chiavacci A, Olmi P. Causes of failure of curative radiation therapy in 205 early glottic cancers. Int J Radiat Oncol Biol Phys 1990;19:1139-1142.
25. Dorresteijn LD, Kappelle AC, Boogerd W, et al. Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years. J Clin Oncol 2002;20:282-288.
26. Statistics Canada. Population. Ottawa, Ontario Canada: Government of Canada; 9-25-2002. Report No.: CANSIM II, table 051-001. Available online: http://www.statcan.ca/english/Pgdb/People/Population/demo02.htm.
27. Statistical Analysis Software. SAS Institute Incorporated 6.1. Cary, North Carolina: SAS is a registered trademark of SAS Institute Inc. in the USA and in other countries; 1996.
28. Robertson AG, Robertson C, Boyle P, et al. The Effect of differing radiotherapeutic schedules on the response of glottic carcinoma of the larynx. Eur J Cancer 1993;29A:501-510.
29. Ang KK, Thames HD, Peters LJ. Altered fractionation schedules. In: Perez CA, Brady LW, eds. Principles and practice of radiation oncology, 3rd edn. Philadelphia: Lippincott-Raven, 1997:19-42.
30. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radol 1989;62:679-694.
31. Mantel N. Chi-Square tests with one degree of freedom: extensions of the Mantel-Haenszel procedure. Am Stat Assoc 1963;58: 690-700.
32. Lustig RA, Maclean CJ, Hanks GE, et al. The patterns of care outcome studies: results of the national practice in carcinoma of the larynx. In J Radiat Oncol Biol Phys 1984;10:2357-2362.
33. Lustig RA, Krall JM, Curran WJ, et al. Improvements observed in care and outcome in carcinoma of the larynx. Int J Radiat Oncol Biol Phys 1991;20:101-104.
34. Priestman TJ, Bullimore JA, Godden TP, et al. The Royal College of Radiologists' fractionation survey. Clin Oncol 1989;1:39-46.
35. Million RR, Cassisi NJ, Parsons JT, et al. Radiation therapy in the management of carcinoma of the larynx. In: Fried MP, ed. The larynx, a multidisciplinary approach, 2nd edn. Boston: Mosby-Year Book, Inc, 1996:571-596.
36. Mittal B, Rao DV, Marks JE, et al. Role of radiation in the management of early vocal cord carcinoma. Int J Radiat Oncol Biol Phys 1983;9:997-1002.
37. Wiernik G, Bleehen NM, Brindle J, et al. Sixth interim progress report of the British Institute of Radiology fractionation study of 3F/week versus 5F/week in radiotherapy of the laryngo-pharynx. Br J Radiol 1978;51:241-250.
38. Rudoltz MS, Benammar A, Mohiuddin M. Prognostic factors for local control and survival in T1 squamous cell carcinoma of the glottis. Int J Radiat Oncol Biol Phys 1993;26:767-772.
39. Schwaibold F, Scariato A, Nunno M, et al. The effect of fraction size on control of early glottic cancer. Int J Radiat Oncol Biol Phys 1988;14:451-454.
40. Kim RY, Marks ME, Salter MM. Early-stage glottic cancer: importance of dose fractionation in radiation therapy. Radiology 1992;182:273-275.
41. Yu E, Shenouda G, Beaudet MP, Black MJ. Impact of radiation therapy fraction size on local control of early glottic carcinoma. Int J Radiat Oncol Biol Phys 1997;37:587-591.
42. Harwood AR, Tiere A. Radiotherapy of early glottic cancer-II. Int J Radiat Oncol Biol Phys 1979;5:477-482.
43. Mendenhall WM, Parsons JT, Million RR. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy: relationship of dose-fractionation factors to local control and complications. Int J Radiat Oncol Biol Phys 1988;15:1267-1273.
44. Mills EE. Early glottic carcinoma: factors affecting radiation failure, results of treatment and sequelae. Int J Radiat Oncol Biol Phys 1979;5:811-817.
45. Wang CC. Treatment of glottic carcinoma by mega-voltage radiation therapy and results. Am J Roentgenol 1974;120:157-163.
46. Kok G. Influence of the size of the fraction dose on normal and tumour tissue in 60C radiation treatment of carcinoma of the larynx and inoperable carcinoma of the breast. Radiol Clin Biol 1971;40:100-115.
47. Fein DA, Lee WR, Hanlon AL, et al. Do overall treatment time, field size, and treatment energy influence local control of T1-T2 squamous cell carcinomas of the glottic larynx? Int J Radiat Oncol Biol Phys 1996;34:823-831.
48. Hoekstra CJM, Levendag PC, van Putten WLJ. Squamous cell carcinoma of the supraglottic larynx without clinically detectable lymph node metastases: problem of local relapse and influence of overall treatment time. Int J Radiat Oncol Biol Phys 1990;18:13-21.
49. Taylor JMG, Withers HR, Mendenhall WM. Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation. Radiother Oncol 1990;17:95-102.
50. Van den Bogaert W, van der Leest A, Rijnders A, et al. Does tumour control decrease by prolonging overall treatment time or interrupting treatment in laryngeal cancer. Radiother Oncol 1995; 36:177-182.
51. Hendry JH, Roberts SA, Slevin NJ, et al. Influence of radiotherapy treatment time on control of laryngeal cancer: comparisons between centres in Manchester, UK and Toronto, Canada. Radiother Oncol 1994;31:14-22.
52. Wang CC, Efird JT. Does prolonged treatment course adversely affect local control of carcinoma of the larynx? Int J Radiat Oncol Biol Phys 1994;29:657-660.
53. Fein DA, Lee WR, Hanlon AL, et al. Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. J Clin Oncol 1995;13:2077-2083.
54. Johansen LV, Overgaard J, Hjelm Hansen M, et al. Primary radiotherapy of T1 squamous cell carcinoma of the larynx: analysis of 478 patients treated from 1963 to 1985. Int J Radiat Oncol Biol Phys 1990;18:1307-1313.
55. Skladowski K, Law MG, Maciejewski B, et al. Planned and unplanned gaps in radiotherapy: the importance of gap position and gap duration. Radiother Oncol 1994;30:109-120.
56. Parsons JT. Time-dose-volume relations in radiation therapy. In: Million RR, Cassisi NJ, eds. Management of head and neck cancer: a multidisciplinary approach, 2nd edn. Philadelphia: J.B. Lippincott Company, 1994:203-243.
57. Olszewski SJ, Vaeth JM, Green JP, et al. The influence of field size, treatment modality, commissure involvement and histology in the treatment of early vocal cord cancer with irradiation. Int J Radiat Oncol Biol Phys 1985;11:1333-1337.
58. Harwood AR. Cancer of the larynx-the Toronto experience. J Otolaryngol 1982;11(suppl 11):1-21.
59. Harwood AR, Hawkins NV, Keane T, et al. Radiotherapy for early glottic cancer. Laryngoscope 1980;90:465-470.
60. Sakata K, Aoki Y, Karasawa K, et al. Radiation therapy in early glottic carcinoma: uni- and multivariate analysis of prognostic factors affecting local control. Int J Radiat Oncol Biol Phys 1994; 30:1059-1064.
61. Fein DA, Mendenhall WM, Parsons JT, et al. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control. Int J Radiat Oncol Biol Phys 1993;25:605-611.
62. Johns HE, Cunningham JR. The interactions of single beams of X and gamma rays with a scattering medium. In: The physics of radiology. 4th ed. Springfield, Illinois, USA: Charles C. Thomas, 1983:336-381.
63. Small W Jr., Mittal B, Brand WN, et al. Results of radiation therapy in early glottic carcinoma: multivariate analysis of prognostic and radiation therapy variables. Radiology 1992; 183:789-794.
64. Lee JH, Machtay M, McKenna MG, et al. Radiotherapy with 6-megavolt photons for early Glottic carcinoma: potential impact of extension to the posterior vocal cord. Am J Otolaryngol 2001; 22:43-54.
65. Dobbs J, Barrett A, Ash D. Head and neck-general considerations for treatment-larynx. 2nd ed. London: Arnold, 1992.
66. Amornmarn R, Prempree T, Viravathana T, et al. A therapeutic approach to early vocal cord carcinoma. Acta Radiol Oncol 1985; 24:321-325.
67. Dickens WJ, Cassisi NJ, Million RR, et al. Treatment of early vocal cord carcinoma: a comparison of apples and apples. Laryngoscope 1983;93:216-219.
68. Abbatucci J, Quint R. Irradiation injury to the nervous system related to radiation therapy of head and neck tumors. In: Kagan AR, Miles JM, eds. Head and neck Oncology: Clinical Management. New York: Permagon Press, 1989:60-68.
69. Antonello M, Polico R, Botner F, et al. The use of a single anterior oblique field in the treatment of T1aN0 vocal cord neoplasms: results and comparison with other techniques. Radiol Med 1995; 90:102-107.
70. Allal AS, Miralbell R, Lehmann W, et al. Effect of arytenoid sparing during radiation therapy of early stage glottic carcinoma primary radiotherapy of T1 and T2 glottic carcinoma: analysis of treatment results and prognostic factors in 223 patients. Radiother Oncol 1997;43:63-65.
71. Jankovic I, Merkas Z. Radiotherapy as the primary approach in the treatment of laryngeal cancer. In: Alberti PW, Bryce DP, eds. Workshops from the centennial conference on laryngeal cancer. New York: Appleton-Century-Crofts, 1976:881-888.
72. Teshima T, Chatani M, Inoue T. Radiation therapy of T1N0M0 glottic carcinoma: clinical evaluations based on field size, plastic shell and wedge filter. Gan No Rinsho 1986;32:141-146.
73. Inoue T, Chatani M, Teshima T, et al. Evaluation of the accuracy in radiotherapy for carcinomas of the hypopharynx and larynx. Gan No Rinsho 1984;30:505-509.
74. Laramore GE. Larynx. In: Laramore GE, ed. Radiation therapy of head and neck cancer. Berlin: Springer-Verlag, 1989:125-143.